{
  "id": 93278,
  "title": "AstraZeneca and Bristol-Myers: when Big Pharma isn’t big enough",
  "url": "https://urgent.news/2026/08/03/astrazeneca-and-bristol-myers-when-big-pharma-isnt-big-enough",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-03T16:33:17.000Z",
  "source": {
    "name": "Financial Times",
    "slug": "financial-times",
    "url": "https://www.ft.com/content/6282b88a-6f49-40cc-b1d8-5e147e7e37f1?syn-25a6b1a6=1"
  },
  "original_language": "en",
  "account": null,
  "summary": "Sheer mass helps when enlarged balance sheets allow for bigger bets on potential blockbuster drugs",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 3,
    "also_reported_by": [
      {
        "outlet": "Handelsblatt",
        "title": "Pharma: AstraZeneca apparently considering mega-merger with US rival Bristol Myers Squibb",
        "url": "https://urgent.news/2026/08/02/pharma-astrazeneca-erwagt-offenbar-mega-fusion-mit-us-rivalen-bristol",
        "published": "2026-08-02T19:26:43.000Z"
      },
      {
        "outlet": "Endpoints News",
        "title": "AstraZeneca, Bristol Myers are in talks about merger — report",
        "url": "https://urgent.news/2026/08/02/astrazeneca-bristol-myers-are-in-talks-about-merger-report",
        "published": "2026-08-02T20:27:37.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}